Their analysis is designed to help surgeons minimize the tissue removed while
operating on cancer patients by providing highly accurate, real - time information about the health of the excised tissue.
Not exact matches
When The
Cancer Genome Atlas Research Network reported its genomic profiling of clear - cell kidney tumours, about one - quarter of participants (126
patients) had been
operated on at Memorial Sloan Kettering3.
By the Duke researchers» calculations, surgeons
operating on patients with a stage T1b tumor (more than 1 cm, but less than 2 cm at its widest point) can be 90 percent sure they have contained the
cancer if they remove 6 lymph nodes around the tumor that test negative for the disease.
Research shows that hospitals that treat more than 20 ovarian
cancer cases a year and surgeons who
operate on more than 10 cases a year have significantly better
patient outcomes than lower volume hospitals and surgeons, according to the Valley Health System.